Royalty Pharma Plc Stock Price History

RPRX Stock  USD 33.70  0.20  0.60%   
Below is the normalized historical share price chart for Royalty Pharma Plc extending back to June 16, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Royalty Pharma stands at 33.70, as last reported on the 21st of March, with the highest price reaching 33.84 and the lowest price hitting 33.25 during the day.
IPO Date
25th of March 1993
200 Day MA
28.2812
50 Day MA
31.9498
Beta
0.471
 
Covid
If you're considering investing in Royalty Stock, it is important to understand the factors that can impact its price. Royalty Pharma appears to be very steady, given 3 months investment horizon. Royalty Pharma Plc maintains Sharpe Ratio (i.e., Efficiency) of 0.28, which implies the firm had a 0.28 % return per unit of risk over the last 3 months. By analyzing Royalty Pharma's technical indicators, you can evaluate if the expected return of 0.51% is justified by implied risk. Please evaluate Royalty Pharma's Semi Deviation of 0.4817, coefficient of variation of 406.25, and Risk Adjusted Performance of 0.2235 to confirm if our risk estimates are consistent with your expectations.
  
At this time, Royalty Pharma's Total Stockholder Equity is fairly stable compared to the past year. Stock Based Compensation is likely to rise to about 2.4 M in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 418.8 M in 2025. . Price To Sales Ratio is likely to drop to 4.79 in 2025. Price Earnings Ratio is likely to drop to 12.63 in 2025. Royalty Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.2757

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsRPRX
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 1.85
  actual daily
16
84% of assets are more volatile

Expected Return

 0.51
  actual daily
10
90% of assets have higher returns

Risk-Adjusted Return

 0.28
  actual daily
21
79% of assets perform better
Based on monthly moving average Royalty Pharma is performing at about 21% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Royalty Pharma by adding it to a well-diversified portfolio.
Price Book
2.0841
Enterprise Value Ebitda
13.0556
Price Sales
8.5313
Shares Float
378.3 M
Dividend Share
0.84

Royalty Pharma Stock Price History Chart

There are several ways to analyze Royalty Stock price data. The simplest method is using a basic Royalty candlestick price chart, which shows Royalty Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceMarch 3, 202533.86
Lowest PriceDecember 20, 202424.76

Royalty Pharma March 21, 2025 Stock Price Synopsis

Various analyses of Royalty Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Royalty Stock. It can be used to describe the percentage change in the price of Royalty Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Royalty Stock.
Royalty Pharma Accumulation Distribution 123,185 
Royalty Pharma Price Daily Balance Of Power 0.34 
Royalty Pharma Price Rate Of Daily Change 1.01 
Royalty Pharma Price Action Indicator 0.26 

Royalty Pharma March 21, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Royalty Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Royalty Pharma intraday prices and daily technical indicators to check the level of noise trading in Royalty Stock and then apply it to test your longer-term investment strategies against Royalty.

Royalty Stock Price History Data

The price series of Royalty Pharma for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 9.74 with a coefficient of variation of 11.09. The price distribution for the period has arithmetic mean of 30.06. The median price for the last 90 days is 31.37. The company completed stock split (1:4) on 15th of October 2010. Royalty Pharma Plc had dividends distributed to its stock-holders on 2025-02-21.
OpenHighLowCloseVolume
03/21/2025 33.30  33.84  33.25  33.70  7,065,366 
03/20/2025 33.44  33.51  33.15  33.50  2,653,625 
03/19/2025 33.33  33.50  33.15  33.41  2,461,117 
03/18/2025 33.06  33.60  33.00  33.41  2,714,404 
03/17/2025 32.82  33.27  32.73  33.02  2,286,214 
03/14/2025 32.57  32.96  32.26  32.77  2,538,657 
03/13/2025 32.85  33.13  32.60  32.68  3,094,377 
03/12/2025 32.31  32.92  32.00  32.85  3,447,279 
03/11/2025 32.77  32.77  32.20  32.46  4,365,177 
03/10/2025 32.94  33.19  32.53  32.75  5,287,736 
03/07/2025 33.28  33.72  32.90  33.01  5,408,072 
03/06/2025 33.75  33.79  33.10  33.28  2,370,802 
03/05/2025 33.11  33.79  33.06  33.77  5,877,763 
03/04/2025 33.85  34.06  33.29  33.32  3,020,616 
03/03/2025 33.76  34.10  33.69  33.86  2,796,810 
02/28/2025 33.56  33.73  33.38  33.64  4,462,138 
02/27/2025 33.06  33.62  32.92  33.37  4,059,617 
02/26/2025 33.53  33.87  33.29  33.38  3,600,340 
02/25/2025 33.77  34.12  33.50  33.69  5,293,008 
02/24/2025 33.47  34.20  33.17  33.80  8,575,168 
02/21/2025 33.29  33.67  33.06  33.42  4,620,588 
02/20/2025 32.07  33.47  32.07  33.11  8,301,150 
02/19/2025 32.62  32.70  32.09  32.37  8,125,649 
02/18/2025 31.83  32.65  31.79  32.63  3,999,679 
02/14/2025 32.25  32.67  32.07  32.15  4,822,379 
02/13/2025 32.18  32.41  31.92  32.25  3,979,839 
02/12/2025 32.06  32.35  31.52  32.13  3,662,225 
02/11/2025 31.39  32.51  31.09  32.04  7,665,260 
02/10/2025 31.52  31.58  31.14  31.51  3,343,504 
02/07/2025 31.27  31.54  31.15  31.52  3,393,408 
02/06/2025 31.41  31.42  31.02  31.19  3,373,705 
02/05/2025 31.13  31.43  30.97  31.24  3,155,070 
02/04/2025 30.83  31.39  30.83  31.05  3,623,559 
02/03/2025 30.86  31.45  30.86  31.12  3,080,007 
01/31/2025 31.43  31.47  31.01  31.37  4,071,952 
01/30/2025 31.72  31.85  31.28  31.38  3,890,145 
01/29/2025 31.79  32.00  31.40  31.74  5,471,126 
01/28/2025 31.61  31.91  31.39  31.73  6,875,643 
01/27/2025 30.90  31.55  30.75  31.51  3,704,130 
01/24/2025 30.41  30.89  30.41  30.86  5,780,103 
01/23/2025 29.93  30.44  29.84  30.42  5,347,998 
01/22/2025 29.89  30.01  29.53  29.88  3,541,447 
01/21/2025 30.59  30.60  30.06  30.10  2,794,612 
01/17/2025 30.52  30.87  30.32  30.55  2,887,148 
01/16/2025 30.44  30.88  29.91  30.75  4,829,577 
01/15/2025 30.03  30.62  29.81  30.54  4,510,597 
01/14/2025 29.70  30.00  29.47  29.83  5,888,176 
01/13/2025 29.63  30.58  29.57  29.79  7,816,924 
01/10/2025 27.37  29.69  27.29  29.30  8,066,463 
01/08/2025 25.81  26.20  25.59  26.03  2,225,778 
01/07/2025 25.46  25.89  25.38  25.87  2,727,346 
01/06/2025 25.56  25.92  25.23  25.58  2,232,329 
01/03/2025 25.64  25.78  25.55  25.67  2,082,916 
01/02/2025 25.38  25.72  25.38  25.62  1,521,459 
12/31/2024 25.13  25.42  25.11  25.34  2,179,396 
12/30/2024 25.24  25.33  25.01  25.15  1,914,509 
12/27/2024 25.10  25.51  25.10  25.37  2,036,094 
12/26/2024 25.02  25.29  24.99  25.23  1,740,149 
12/24/2024 25.06  25.18  24.85  25.06  1,350,225 
12/23/2024 24.56  25.09  24.30  25.08  5,439,334 
12/20/2024 24.18  24.83  24.15  24.76  7,574,662 

About Royalty Pharma Stock history

Royalty Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Royalty is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Royalty Pharma Plc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Royalty Pharma stock prices may prove useful in developing a viable investing in Royalty Pharma
Last ReportedProjected for Next Year
Common Stock Shares Outstanding592.7 M418.8 M
Net Income Applicable To Common Shares49.3 M46.8 M

Royalty Pharma Quarterly Net Working Capital

548.52 Million

Royalty Pharma Stock Technical Analysis

Royalty Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Royalty Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Royalty Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Pattern Recognition Now

   

Pattern Recognition

Use different Pattern Recognition models to time the market across multiple global exchanges
All  Next Launch Module

Royalty Pharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Royalty Pharma's price direction in advance. Along with the technical and fundamental analysis of Royalty Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Royalty to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Royalty Stock Analysis

When running Royalty Pharma's price analysis, check to measure Royalty Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Royalty Pharma is operating at the current time. Most of Royalty Pharma's value examination focuses on studying past and present price action to predict the probability of Royalty Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Royalty Pharma's price. Additionally, you may evaluate how the addition of Royalty Pharma to your portfolios can decrease your overall portfolio volatility.